据 IW jan 2009 报导.A skilled workforce at medical-device maker Cordis LLC's Pyerto Rico plant attracts new business during challenging times.
No:9212
Wednesday, 14 January 2009
Bristol in development deal
据 wsj 元月13日报导. Bristol-myers squibb co. said it will team with Zymogenetics inc. to develop a hepatitis C treatment,in a deal that could eventually bring zymogenetics more than $1 billion.
No:9211
No:9211
Tuesday, 13 January 2009
Indevus Pharmaceuticals stock
据 wsj 元月7日报导. On the deals front, large-cap Endo Pharmaceuticals agreed to acquire smaller pharmaceuticals in a deal that pays a 45% premium from the company's stock price at the close of monday'ssession.Indevus,based in Lexington,Mass.,closed up 2.28,or 74%,at 5.38.
(small stock)
No :9207
(small stock)
No :9207
Immucor stock
据 wsj 元月9日报导. Immucor raised its 2009 earnings guidance and backed its 2009 revenue outlook, sending shares of the Norcross,Ga.,maker of blood-transfusion testing systems up 2.98, or 13%,to 26.48. (small stock)
No :9205
No :9205
Akorn stock
据 wsj 元月2日报导. Akorn stock soared as much as 53% wednesday before settling up 35 cents,or 18% to 2.30 after the joint venture it formed with india-based Strides Arcolab was granted approvals for two of its generic antibiotic products by the FDA. (small stock )
No :9204
No :9204
Medicare seeks to ban some penalties for picking Brand-name druges
据 wsj 元月10日报导. the Bush administration proposed banning a practice that lets private insurers charge Medicare beneficiaries stiff penalties if they choose brand-name drugs instead of cheaper generics.
No:9203
No:9203
Merckles plan to shed drug firm
据 wsj 元月8日报导. Frankfurt 消息,the family of deceased German billionaire Adolf Merckle said Wednesday it will put generic drug maker Ratiopharm Gmbh up for sale after securing a bridge loan to prop up the teetering family business empire.
No :9208
No :9208
Vytorin use should continue ,FDA says
据 swj 元月9日报导. the patients should not stop taking vytorin or other cholesterol-lowering drugs, based on its just-completed review of a controversial study that hammered vytorin sales.
No : 9201
No : 9201
on a hunt,Wyeth seeks Dutch maker of vaccines
据 wsj 元月8日报导.Wyeth is in talks to purchase Dutch vaccine maker Crucell NV as the big U.S. drug maker attempys to grab a larger share of one of the industry's fastest-growing segments.
no: 9209
no: 9209
亚博特并购先进医疗
元月13月世界日报及其他英文报纸都刊登了这消息。亚博特股票12日下跌2.17%,收在50.06元;先进医疗(advanced medical optics)则上升142.94%,收在21.5元.
Sunday, 4 January 2009
Generic drug 学名药
大学同学严钟达博士E-mail 我4份资料,都来自 C & EN,作者是jian-Francois Trembiay. 二篇报导中国,由政府主导拨款 $1 billion 来支持医药实验室.其中有"海归"主持的,也有原来中科院上海药物所。二篇报导印度,有关专利法的修订,以保护广大贫困者能用到低价的药.为此因Roche 的Tarceva
和Cipla的Erlocip 发生专利诉讼,法院判印度药公司不侵权. 中国人大正在修订中国专利法.
和Cipla的Erlocip 发生专利诉讼,法院判印度药公司不侵权. 中国人大正在修订中国专利法.
Subscribe to:
Posts (Atom)